Assessment of a New Formulation of Sildenafil on Common Practice: An Observational Study

Figure 2

Response rate at V3 in each group and overall population. Group 1 (mild); Group 2 (moderate); Group 3 (severe) ED; Group 4 (previous treatment with other PDE5-Is).